BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 25044020)

  • 21. The peptide-hormone glucagon-like peptide-1 activates cAMP and inhibits growth of breast cancer cells.
    Ligumsky H; Wolf I; Israeli S; Haimsohn M; Ferber S; Karasik A; Kaufman B; Rubinek T
    Breast Cancer Res Treat; 2012 Apr; 132(2):449-61. PubMed ID: 21638053
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The glucagon-like peptide-1 receptor agonist oxyntomodulin enhances beta-cell function but does not inhibit gastric emptying in mice.
    Maida A; Lovshin JA; Baggio LL; Drucker DJ
    Endocrinology; 2008 Nov; 149(11):5670-8. PubMed ID: 18669601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. GRK Inhibition Potentiates Glucagon-Like Peptide-1 Action.
    Lee SP; Qi J; Xu G; Rankin MM; Littrell J; Xu JZ; Bakaj I; Pocai A
    Front Endocrinol (Lausanne); 2021; 12():652628. PubMed ID: 34054727
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adenylyl cyclase 8 is central to glucagon-like peptide 1 signalling and effects of chronically elevated glucose in rat and human pancreatic beta cells.
    Roger B; Papin J; Vacher P; Raoux M; Mulot A; Dubois M; Kerr-Conte J; Voy BH; Pattou F; Charpentier G; Jonas JC; Moustaïd-Moussa N; Lang J
    Diabetologia; 2011 Feb; 54(2):390-402. PubMed ID: 21046358
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An incretin-based tri-agonist promotes superior insulin secretion from murine pancreatic islets via PLC activation.
    Khajavi N; Finan B; Kluth O; Müller TD; Mergler S; Schulz A; Kleinau G; Scheerer P; Schürmann A; Gudermann T; Tschöp MH; Krude H; DiMarchi RD; Biebermann H
    Cell Signal; 2018 Nov; 51():13-22. PubMed ID: 30055232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New Insights into Beta-Cell GLP-1 Receptor and cAMP Signaling.
    Tomas A; Jones B; Leech C
    J Mol Biol; 2020 Mar; 432(5):1347-1366. PubMed ID: 31446075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New screening strategy and analysis for identification of allosteric modulators for glucagon-like peptide-1 receptor using GLP-1 (9-36) amide.
    Nakane A; Gotoh Y; Ichihara J; Nagata H
    Anal Biochem; 2015 Dec; 491():23-30. PubMed ID: 26341912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased TCF7L2 protein levels in type 2 diabetes mellitus correlate with downregulation of GIP- and GLP-1 receptors and impaired beta-cell function.
    Shu L; Matveyenko AV; Kerr-Conte J; Cho JH; McIntosh CH; Maedler K
    Hum Mol Genet; 2009 Jul; 18(13):2388-99. PubMed ID: 19386626
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glucagon Acting at the GLP-1 Receptor Contributes to β-Cell Regeneration Induced by Glucagon Receptor Antagonism in Diabetic Mice.
    Wei T; Cui X; Jiang Y; Wang K; Wang D; Li F; Lin X; Gu L; Yang K; Yang J; Hong T; Wei R
    Diabetes; 2023 May; 72(5):599-610. PubMed ID: 36826938
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progesterone increases blood glucose via hepatic progesterone receptor membrane component 1 under limited or impaired action of insulin.
    Lee SR; Choi WY; Heo JH; Huh J; Kim G; Lee KP; Kwun HJ; Shin HJ; Baek IJ; Hong EJ
    Sci Rep; 2020 Oct; 10(1):16316. PubMed ID: 33005004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Novel GLP1 Receptor Interacting Protein ATP6ap2 Regulates Insulin Secretion in Pancreatic Beta Cells.
    Dai FF; Bhattacharjee A; Liu Y; Batchuluun B; Zhang M; Wang XS; Huang X; Luu L; Zhu D; Gaisano H; Wheeler MB
    J Biol Chem; 2015 Oct; 290(41):25045-61. PubMed ID: 26272612
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of glucagon-like peptide-1 receptor and glucose‑dependent insulinotropic polypeptide receptor is regulated by the glucose concentration in mouse osteoblastic MC3T3-E1 cells.
    Aoyama E; Watari I; Podyma-Inoue KA; Yanagishita M; Ono T
    Int J Mol Med; 2014 Aug; 34(2):475-82. PubMed ID: 24866833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GLP-1 receptor localization in monkey and human tissue: novel distribution revealed with extensively validated monoclonal antibody.
    Pyke C; Heller RS; Kirk RK; Ørskov C; Reedtz-Runge S; Kaastrup P; Hvelplund A; Bardram L; Calatayud D; Knudsen LB
    Endocrinology; 2014 Apr; 155(4):1280-90. PubMed ID: 24467746
    [TBL] [Abstract][Full Text] [Related]  

  • 34. cAMP-secretion coupling is impaired in diabetic GK/Par rat β-cells: a defect counteracted by GLP-1.
    Dolz M; Movassat J; Bailbé D; Le Stunff H; Giroix MH; Fradet M; Kergoat M; Portha B
    Am J Physiol Endocrinol Metab; 2011 Nov; 301(5):E797-806. PubMed ID: 21750265
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antagonism of rat beta-cell voltage-dependent K+ currents by exendin 4 requires dual activation of the cAMP/protein kinase A and phosphatidylinositol 3-kinase signaling pathways.
    MacDonald PE; Wang X; Xia F; El-kholy W; Targonsky ED; Tsushima RG; Wheeler MB
    J Biol Chem; 2003 Dec; 278(52):52446-53. PubMed ID: 14565957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glucagon-like peptide-1 receptor is present in pancreatic acinar cells and regulates amylase secretion through cAMP.
    Hou Y; Ernst SA; Heidenreich K; Williams JA
    Am J Physiol Gastrointest Liver Physiol; 2016 Jan; 310(1):G26-33. PubMed ID: 26542397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic stability, receptor binding, cAMP generation, insulin secretion and antihyperglycaemic activity of novel N-terminal Glu9-substituted analogues of glucagon-like peptide-1.
    Green BD; Gault VA; Irwin N; Mooney MH; Bailey CJ; Harriott P; Greer B; Flatt PR; O'Harte FP
    Biol Chem; 2003 Dec; 384(12):1543-51. PubMed ID: 14719796
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic and biased agonist-mediated reductions in β-arrestin recruitment prolong cAMP signaling at glucagon family receptors.
    Jones B; McGlone ER; Fang Z; Pickford P; Corrêa IR; Oishi A; Jockers R; Inoue A; Kumar S; Görlitz F; Dunsby C; French PMW; Rutter GA; Tan T; Tomas A; Bloom SR
    J Biol Chem; 2021; 296():100133. PubMed ID: 33268378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GLP-1 and GIP receptor signaling in beta cells - A review of receptor interactions and co-stimulation.
    Mayendraraj A; Rosenkilde MM; Gasbjerg LS
    Peptides; 2022 May; 151():170749. PubMed ID: 35065096
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional receptors for the insulinotropic hormone glucagon-like peptide-I(7-37) on a somatostatin secreting cell line.
    Fehmann HC; Habener JF
    FEBS Lett; 1991 Feb; 279(2):335-40. PubMed ID: 1672112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.